Mergers & Acquisitions - Biotechnology, Global

Filter

Current filters:

BiotechnologyGlobal

Popular Filters

Sustainability of sky-high M&A valuations will be the biggest question for 2014, says new report

12-03-2014

The cautious optimism of 2012 turned into a fully fledged biotech boom in 2013, marked by surging company…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Pharma M&A deals in 2013 down, but values marginally higher

Pharma M&A deals in 2013 down, but values marginally higher

13-01-2014

Merger and acquisition activity in the pharmaceutical, biotechnology and generic drugs sectors continued…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Health care M&A spending falls nearly 40% in 2012, lowest year on record since 2003; report

22-01-2013

In 2012, dealmakers committed $143.3 billion to finance the year's activity in the health care merger,…

BiotechnologyGlobalMergers & AcquisitionsPharmaceutical

Global biotechnology market set to exceed $320 billion by 2015, says GIA

25-01-2012

The biotechnology industry was adversely affected by the global financial crisis, with several leading…

BiotechnologyGlobalMarkets & MarketingMergers & AcquisitionsResearch

Back to top